|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61P 35/00 | |||
| C07K 16/30 | |||
| C07K 16/28 |
| (11) | Number of the document | 2654789 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11801741.7 |
| Date of filing the European patent application | 2011-12-21 | |
| (97) | Date of publication of the European application | 2013-10-30 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/073659 |
| Date | 2011-12-21 |
| (87) | Number | WO 2012/085132 |
| Date | 2012-06-28 |
| (30) | Number | Date | Country code |
| 201061426041 P | 2010-12-22 | US |
| (72) |
BENSUSSAN, Armand, FR
BONNEFOY-BERARD, Nathalie, FR
ELIAOU, Jean-Franēois, FR
ALBERICI, Gilles, FR
BASTID, Jeremy, FR
|
| (73) |
INSERM - Institut National de la Santé et de la Recherche Médicale,
101, rue de Tolbiac, 75013 Paris,
FR
Orega Biotech, 15 Chemin du Saquin L`Espace Européen - Bātiment G, 69130 Ecully, FR |
| (54) | ANTIBODIES AGAINST HUMAN CD39 AND USE THEREOF |
| ANTIBODIES AGAINST HUMAN CD39 AND USE THEREOF |